Asymmetry Capital Management as of March 31, 2021
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 29 positions in its portfolio as reported in the March 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Jazz Pharmaceuticals (JAZZ) | 6.3 | $12M | 74k | 164.37 | |
Sotera Health (SHC) | 6.0 | $12M | 467k | 24.96 | |
Adaptive Biotechnologies Cor (ADPT) | 6.0 | $12M | 288k | 40.26 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 6.0 | $12M | 54k | 214.89 | |
Arena Pharmaceuticals | 5.9 | $11M | 163k | 69.39 | |
Insulet Corporation (PODD) | 5.8 | $11M | 43k | 260.91 | |
UnitedHealth (UNH) | 5.7 | $11M | 29k | 372.07 | |
Astrazeneca Plc-spons Adr (AZN) | 5.6 | $11M | 219k | 49.72 | |
Guardant Health (GH) | 4.9 | $9.5M | 62k | 152.64 | |
Nanostring Technologies (NSTGQ) | 4.8 | $9.4M | 143k | 65.71 | |
Biodesix (BDSX) | 4.7 | $9.0M | 444k | 20.31 | |
Essa Pharma (EPIX) | 4.3 | $8.3M | 285k | 29.05 | |
Kura Oncology (KURA) | 4.1 | $7.8M | 278k | 28.27 | |
Arcus Biosciences Incorporated (RCUS) | 3.4 | $6.6M | 237k | 28.08 | |
Avadel Pharmaceuticals Adr (AVDL) | 3.3 | $6.4M | 712k | 9.04 | |
Sage Therapeutics (SAGE) | 3.1 | $6.0M | 80k | 74.85 | |
Jounce Therapeutics | 2.8 | $5.3M | 521k | 10.27 | |
Aslan Pharmaceuticals Lt- Adr | 2.3 | $4.5M | 1.4M | 3.35 | |
Mirati Therapeutics | 2.1 | $4.2M | 24k | 171.29 | |
Renalytix Ai Plc- Adr (RNLX) | 2.1 | $4.1M | 161k | 25.66 | |
Pmv Pharmaceuticals (PMVP) | 2.0 | $3.9M | 118k | 32.89 | |
Mereo Biopharma Group Plc ads (MREO) | 1.9 | $3.6M | 1.1M | 3.37 | |
Iteos Therapeutics (ITOS) | 1.8 | $3.5M | 102k | 34.18 | |
Regulus Therapeutics | 1.6 | $3.1M | 2.0M | 1.56 | |
Apricus Biosciences | 1.1 | $2.2M | 441k | 4.99 | |
Forte Biosciences (FBRX) | 0.9 | $1.8M | 53k | 34.27 | |
Turning Point Therapeutics I | 0.6 | $1.1M | 12k | 94.58 | |
Bcls Acquisition Corp | 0.5 | $871k | 82k | 10.57 | |
Galecto (GLTO) | 0.4 | $690k | 114k | 6.08 |